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Noninvasive cardiac imaging, either at rest or during stress, has 
been for many years an integral part of evahrating and 
managing patients with suspected or known coronary artery 
disease. In the present era, when appropriate use of resources 
is under heavy scrutiny, the use of noninvasive imaging modal- 
ities can be expected to increase, further serving as effective 
gatekeepers for triaging and directing patients toward appro- 
priate management strategies (1). In this value-driven environ- 
ment, radiiuciide myocardird perfusiin imaging will play an 
important role for two reasons: the ability to assess the 
fmmtionai significance of anatomic coronary artery disease and 
the ability to quantify such variables. In recent years the 
methodology of interpreting myocardial perfusion images has 
changed accordiig to the clinical questions posed. 
Stress testing in patients with corouary artery disc= aims 
to reproduce a patient’s symptoms and to elicit unequivocal 
objedve evidence of myocardird is&et&. This is entirely 
dependent on the ability of a stress modality to achieve 
metabolic demand-supply imbahmce and thus myocardiai isch- 
emia. There are multiple clinical reasons wby this may not 
ahvays be successfuk tack of patient motivation, inability to 
exercim and inability to achieve appropriate work load. 
The advantage of stress radionttclide imaging is that abnormal- 
ities on the perfmion image do not depend on provocation of 
true myocardial iscbemia. The. underlying principle of an 
abnormal response to radionucbde stress myocmdial perfusion 
imaging is the creation of heterogeneity of regional myocardial 
bkwl ih because of di@erences in coronary blood Row 
rescm m vascuIar territories supplied by normal and stenosed 
coronary arteries. Elhendy et al. (2) in a recent issue of the 
Journal observed that 26% of patients with reversible singte- 
photon em&ion computed tomographic (SPFXT) myocardial 
perfusion defects had no evidence of myocardial ischemia (i.e., 
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wall motion abnormalities on echocardiography) during the 
same dobutamine stress test. Heterogeneity of myocardial 
blood flow or regional myocardial hypoperfusion is known to 
precede metabolic evidence of myocardial ischemia and re- 
gional contraction abnormalities. Eihendy et al. (2) hypothe- 
sized that in patients with (false) negative dobutamine stress 
echocardiographic results, the achieved level of stress or the 
quantitative extent of scintigraphic abnormalities, or both, 
would be less than that in patients with ischemic wall motion 
abnormalities. Indeed, the stress rate-pressure product was 
lower in these patients, but no difference was seen in the extent 
or severity of reversible myocardial perfusion abnormalities. 
This finding is consistent with the concept that myocardial 
blood flow heterogeneity, extensive or not, is not necessarily 
temporally associated with provoked &hernia. Thus, stress 
myocardial perfusion imaging can be expected to detect signif- 
icant coronary artery disease earlier than techniques that 
depend on provocation of &hernia. 
Qnanti6catfon of fschemic burden. Another strength of 
radionuclide myocardial perfusion imaging is the widespread 
use of computer quantitication of relative myocardial radii 
tracer uptake. This quantification can readily be done because 
radionuchde images are inherently quantitative: The number 
and location of scintillations detected by the gamma camera 
are stored in a computer matrix. Image quantification can be 
performed using either bugs-eye or circumferential profile 
analysis. Using both approaches, a patient’s relative myocar- 
dial radiotracer uptake is quantitatively compared with that 
from normal data files, representing the lower limits of normal 
radiotracer distribution (3,4). This comparison allows for ob- 
jective and, importantly, reproducible quantification of stress- 
induced regional myocardial perfusion abnormalities, as well 
as quantihcation of defect reverstbity. The latter allows for 
quantitative assessment of the degree and extent of coronary 
tlow heterogeneity, which relates to the functional significance 
of angiographic coronary artery disease and the potential 
“total iszhernic burden” if true ischemia were to be provoked. 
The extent of perfusion abnormalities has been shown to be 
associated strongly with patient outcome (5,6). The larger the 
exercise-induced myocardial perfusion abnormality, defect re- 
versibility and extent of rest perfusion defect, the more the 
patient’s prognosis is likely to be compromised by the occur- 
rencc of a future cardiac event. It is therefore important in 
cliical practice to report the quantitative extent of stress- 
induced myocardiai perfusion abnormalities. 
Elhendy et al. (2) used quantitative technetium-!99m sesta- 
mrbi dobutamine stress SPECT imaging to quantify the extent 
of myocardia) iscbemia. They did not neeessariiy assess and 
quantify the extent of myocardial is&e* rather, they quan- 
tifred the extent of the dobutamine-induced blood fiow heter- 
o~eneity. l&se scintjgrapbic abmmalities were in -25% of 
patients not associated with true myooudial ischemia and 
dobutamine-induced echocardiographic wall motion abnor- 
malities. 
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Myocardtal viability, a quantifiable continuum. Radionu- 
elide myocardial perfusion imaging at rest ;a lacreasingly used 
to assess myocardial viability (7). This assessment is of partic- 
ular clinical relevance in patients with known coronary artery 
disease and left ventricuiar dysfunction who are constdered for 
coronary revascularixation. For the purpose of dstermining 
myocardial viability, image analysis is to be focused differently 
than that for stress myocardial perfusion imaging. It is not 
relevant to assess whether a certa4r myocardial segment has 
less radiotracer accumulation, but how much radiotracer is 
actually accumulated. The glass is not to be viewed as half 
empty (as is appropriate for stress myocardial perfusion imag- 
ing), but as half full. For assessment of myocardial viability. 
considerable emphasis has been placed on the amount of rest 
radiotracer uptake (8). As mentioned before, quantification of 
relative myocardial radiopharmaceutical uptake can readily be 
obtained using available computer software. Clinical studies 
comparing rest thallium-201 Jptske with evidence for active 
myocardial metabolism by positron emission tomographic im- 
aging or improvement of regional wall motion after revascu- 
larizttion, or both, have established the notion that a threshold 
exists below which myocardial revascularization is apparently 
not useful. The concept that myocardial segments containing 
at least 50% of normal thallium-201 uptake are viable and are 
appropriate targets for coronary revascularization is now 
widely accepted. As a corollary. myocardial segmenis with 
<SO% of normal thallium-201 uptake are generally thought to 
be scar tissue that would not benefit from revascularization. 
However, this reasoning is an oversimplification of issues 
related to myocardial viability and the usefirlness of revascu- 
larization. fnfarctions are often not complete and may be 
nontransmural. As long as some amount of viable myocardium 
is present in a myocardial segment, depending on the ratio of 
the mixture of viable to nonviable cells, myocardial imaging 
with agents that track myocardial viability may show slightly, 
moderately or markedly decreased radiotracer uptake on 
tomographic images. The aforementioned 50% threshold of 
radiotracer uptake relates to the likelihood that regional wall 
motion in such a segment improves after revascularization. 
However, although improvement in regional function is a 
rewarding result of revascularixation, the most common pur- 
pose of revascularization is the relief myocardial ischemia. 
Myocardial segments with <5ti of norm; radiopharmaceu- 
tical uptake may contain viable cells that potentially may 
become irhemic during stress and ultimately may infarct. It is 
not unusuai to observe partially reversxble myocardial perfu- 
sion defects in areas with severely reduced (4W of normal) 
rest radiotracer uptake. Revascularization of such segments is 
not meaningless, although it may not be associated with 
improved regional wall motion. 
To make such assessments about a patient‘s myocardial 
status, quantification of myocardiil petfusion images is impor- 
tant. Furthemmre, an ttndenrartding of the characteristics of 
radiitracet5 is important. The ,tttique properties of thallium- 
201 for assess@ myocardial viability are well docmnented. 
WACKERS 1599 
EDITORIAL COMMEhT 
New technetium-99m-labeled myocardial perfusion imaging 
agents, such as scstamibi. have significantly improved the 
quality of SPECT myocardial perfusion imaging. However, 
because the mechanism of myocardial uptake of sestamibi 
differs from that of thallium-201, the reliability of this agent as 
a marker of myocardial viability has bcen questioned, in 
particular. under conditions of low rest myocardial blood flow 
(9). Kauffman et al. (10) in this issue of the Journal, demon- 
strate quantitatively that rest regional myocardial uptake of 
sestamibi in patients with ischemic regional left ventricular 
function is comparable to that of thallium-201. Nevertheless, in 
individual patients. thallium-201 and sestamibi images were 
not always identical. Casing 50% of normal radiotracer uptake 
as a threshold. discordance occurred in 12% of patients. This 
threshold for myocardial viability is an empirically determined 
cutoff value. Myocardial viability should instead be viewed as a 
continuum. There is probably no true clinical difference be- 
tween segments that are measured as having. for example, 519 
versus 45? of normal radiotracer uptake. Moreover, due to 
physical differences between thallium-201 and technetium- 
99m, images obtained of the same objeb? are not identical. For 
instance. a given perfusion defect mav ‘be quantitatively less 
severe on a scintigraphic image obtained with thallium-201 
than on one obtained with sestamibi because of the larger 
amount of low energy scatter with thallium-201. It is therefore 
important to consider the quantitative methodology used in 
the study by Kauffman et al. (IO). Rather than using circum- 
ferential protiles of tomographic slices that allow for detailed 
segmental comparisons in individual patients, which is appro- 
priate when comparing stress-rest uptake. average vahtes in 
relatively large bull’seye map segments were used that 
“smooth out“ relatively small and clinically insignificant differ- 
ences between the two radiotracers Using this averaging 
approach, no statistical difference was seen between segments 
with mildly and severely reduced rest thallium-201 and sesta- 
mibi uptake. These observations provide a further scientific 
basis to the growing clinical experience that rest sestamtbi 
myocardial perfusion imaging can be used successfully for 
quantitative assemment of myocardial viability. 
Roth studies (2.10) illustrate that radionuclide myccardiil 
perfusion images should not bc interpreted in a binary fashion: 
normal or abnormal. viable or scar. Computer quantihcation of 
radionuclidc myocardiaj perfusion images shows a mJre Yr 
phisticated approach: on the one hand. quantitative assess- 
ment of heterogeneity of coronary flow reserve, and on the 
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